Women and lung cancer: Does oestrogen play a role?

Lancet Oncology

Volumn 2, Issue 8, 2001, Pages 506-513

  Siegfried, Jill M ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN;

ARTICLE; COMPARATIVE STUDY; EPIDEMIOLOGY; FEMALE; HUMAN; LUNG TUMOR; MALE; PHYSIOLOGY; RISK FACTOR; SEX DIFFERENCE; SMOKING;

CAUSALITY; ESTROGENS; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; RISK FACTORS; SEX FACTORS; SMOKING;

EID: 0035436526     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(01)00457-0     Document Type: Note

References (78)

1. Tobacco use - United States, 1900-1999. Mor Mortal Wkly Rep. 48:1999;986-993.
2. State-specific prevalence among adults of current cigarette smoking and smokeless tobacco use and per capita tax-paid sales of cigarettes - United States, 1997. Mor Mortal Wkly Rep 1998; 47: 922-26.
3. United States Department of Health and Human Services. Cigarette smoking among high school students - 11 States, 1991-1997. Mor Mortal Wkly Rep 1998; 47: 686-92.
4. Kandel D.B., Chen K. Extent of smoking and nicotine dependence in the United States: 1991-1993. Nicotine Tobacco Res. 2:2000;263-274.
5. Jarry J.L., Coambs R.B., Polivy J., et al. Weight gain after smoking cessation in women: the impact of dieting status. Int J Eat Disord. 24:1998;53-64.
6. Crisp A.H., Stavrakaki C., Halek C., et al. Smoking and pursuit of thinness in schoolgirls in London and Ottowa. Postgrad Med J. 74:1998;473-479.
7. DiFranza J.R., Lew R.A. Effect of maternal cigarette smoking on pregnancy complications and sudden infant death syndrome. J Fam Prac. 40:1995;385-394.
8. United States Department of Health and Human Services: The Health Consequences of Smoking for Women. A Report of the Surgeon General. Washington, DC, US Department of Health and Human Services, Public Health Service, Office of the Assistant Secretary for Health, Office on Smoking and Health 1980; 8411.
9. Landis S.H., Murray T., Bolden S., et al. Cancer statistics. CA Cancer J Clin. 49:1999;8-31.
10. Tanoue L.T. Cigarette smoking and women's respiratory health. Clin Chest Med. 21:2000;47-65.
11. United States Department of Health and Human Services. Women and smoking: a report of the Surgeon General - 2001. Washington DC: USDepartment of Health and Human Services, Center for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. Available at www.surgeongeneral.gov/library.
12. Zang E.A., Wynder E.L. Differences in lung cancer risk between men and women: examination of the evidence. J Natl Cancer Inst. 88:1996;183-192.
13. Baldini E.H., Strauss G.M. Women and lung cancer: waiting to exhale. Chest. 112:1997;229S-239S.
14. Brownson R.C., Chang J.C., Davis J.R. Gender and histologic type variations in smoking-related risk of lung cancer. Epidemiology. 3:1992;61-64.
15. McDuffie H.H., Klaassen D.J., Dosman J.A. Female-male differences in patients with primary lung cancer. Cancer. 59:1987;1825-1830.
16. Risch H.A., Howe G.R., Jain M., et al. Are female smokers at higher risk for lung cancer than male smokers? Am J Epidemiol. 138:1993;281-293.
17. Xu X., Weiss S.T., Rijcken B., et al. Smoking, changes in smoking habits, and rate of decline in FEV: new insight into gender differences. Eur Respir J. 7:1994;1056-1061.
18. Chen Y., Horne S.L., Dosman J.A. Increased susceptibility to lung dysfunction in female smokers. Am Rev Respir Dis. 143:1991;1224-1230.
19. Prescott E., Bjerg A.M., Andersen P.K., et al. Gender difference in smoking effects on lung function and risk of hospitalization for chronic obstructive pulmonary disease: results from a Danish longitudinal population study. Eur Respir J. 10:1997;822-827.
20. Xu X., Li B., Wang L. Gender difference in smoking effects on adult pulmonary function. Eur Respir J. 7:1994;477-483.
21. Kirsh M.M., Tashian J., Sloan H. Carcinoma of the lung in women. Ann Thorac Surg. 34:1982;34-39.
22. Ferguson M.K., Wang J., Hoffman P.C., et al. Sex-associated differences in survival of patients undergoing resection for lung cancer. Ann Thorac Surg. 69:2000;245-249.
23. Greenberg R.E., Korson R., Baker J., et al. Incidence of lung cancer by cell type: a population-based study in New Hampshire and Vermont. J Natl Cancer Inst. 72:1984;599-603.
24. Lubin J.H., Blot W.J. Assessment of lung cancer risk factors by histologic category. J Natl Cancer Inst. 73:1984;383-389.
25. Mitsudomi T., Tateishi M., Oka T., et al. Longer survival after resection of non-small cell lung cancer in Japanese women. Ann Thorac Surg. 48:1989;639-642.
26. Osann K.E., Anton-Culver H., Kurosaki T., et al. Sex differences in lung-cancer risk associated with cigarette smoking. Int J Cancer. 54:1993;44-48.
27. Schwartz A.G., Yang P., Swanson G.M. Familial risk of lung cancer among nonsmokers and their relatives. Am J Epidemiol. 144:1996;554-562.
28. Satoh J., Yamashita Y.T., Ishikawa H., et al. Smoking and smoking-related lung cancer in female patients. Anticancer Res. 19:1999;5627-5630.
29. de Perrot M., Licker M., Bouchardy C., et al. Sex differences in presentation, management, and prognosis of patients with non-small cell lung carcinoma. J Thorac Cardiovasc Surg. 119:2000;21-26.
30. Kreuzer M., Boffetta P., Whitley E., et al. Gender differences in lung cancer risk by smoking: A multicentre cancer-control study in Germany and Italy. Br J Cancer. 82:2000;227-233.
31. Muscat J.E., Richie J.P., Thompson S., et al. Gender differences in smoking and risk for oral cancer. Cancer Res. 56:1996;5192-5197.
32. Ernster V.L. Female lung cancer. Annu Rev Public Health. 17:1996;97-114.
33. Halpern M.T., Gillespie B.W., Warner K.E. Patterns of absolute risk of lung cancer mortality in former smokers. J Natl Cancer Inst. 85:1993;457-464.
34. Alavanja M.C.R., Brownson R.C., Benichou J., et al. Attributable risk of lung cancer in lifetime nonsmokers and long-term ex-smokers (Missouri, United States). Cancer Causes Control. 6:1995;209-216.
35. Jee S.H., Ohrr H., Kim I.S. Effects of husbands' smoking on the incidence of lung cancer in Korean women. Int J Epidemiol. 28:1999;824-828.
36. Bennett W.P., Alavanja M.C.R., Blomeke B., et al. Environmental tobacco smoke, genetic susceptibility, and risk of lung cancer in never-smoking women. J Natl Cancer Inst. 91:1999;2009-2014.
37. Alavanja M.C.R., Brownson R.C., Lubin J.H., et al. Residential radon exposure and lung cancer among nonsmoking women. J Natl Cancer Inst. 86:1994;1829-1837.
38. Steck D.J., Field R.W., Lynch C.F. Exposure to atmospheric radon. Environ Health Perspect. 107:1999;123-127.
39. Gao Y., Blot W.J., Zheng W., et al. Lung cancer among Chinese women. Int J Cancer. 40:1987;604-609.
40. Cheng Y.-W., Chiou H.-L., Sheu G.-T., et al. The association of human papilloma virus 16/18 infection with lung cancer among nonsmoking Taiwanese women. Cancer Res. 61:2001;2799-2803.
41. Reynolds P. Epidemiologic evidence for workplace ETS as a risk factor for lung cancer among nonsmokers: specific risk estimates. Environ Health Perspect. 107:(suppl 6):1999;865-872.
42. Kabat G.C., Stellman S.D., Wynder E.L. Relation between environmental tobacco smoke and lung cancer in lifetime nonsmokers. Am J Epidemiol. 142:1995;141-148.
43. Alavanja M.C.R., Brownson R.C., Boice J.D., et al. Preexisting lung disease and lung cancer among nonsmoking women. Am J Epidemiol. 136:1992;623-632.
44. Hinds M.W., Cohen H.I., Kolonel L.N. Tuberculosis and lung cancer risk in nonsmoking women. Am Rev Respir Dis. 125:1982;776-778.
45. Mayne S.T., Buenconsejo J., Janerich D.T. Previous lung disease and risk of lung cancer among men and women. Am J Epidemiol. 149:1999;13-20.
46. Chen Y., Breithaupt K., Muhajarine N. Occurrence of chronic obstructive pulmonary disease among Canadians and sex-related risk factors. J Clin Epidemiol. 53:2000;755-761.
47. Yeatts K., Shy C., Wiley J., et al. Statewide adolescent asthma surveillance. J Asthma. 37:2000;425-434.
48. Omland O., Sigsgaard T., Hjort C., et al. Lung status in young Danish rurals: the effect of farming exposure on asthma-like symptoms and lung function. Eur Respir J. 13:1999;31-37.
49. Prudhomme A. Influence du sexe feminine sur l'asthme [Influence of female sex on asthma]. Rev Pneumol Clin. 55:1999;296-300.
50. Kure E.H., Ryberg D., Hewer A., et al. p53 mutations in lung tumours: relationship to gender and lung DNA adduct levels. Carcinogenesis. 17:1996;2201-2205.
51. Ryberg D., Hewer A., Phillips D.H., et al. Different susceptibility to smoking-induced DNA damage among male and female lung cancer patients. Cancer Res. 54:1994;5801-5803.
52. Wei Q., Cheng L., Amos C.I., et al. Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiologic study. J Natl Cancer Inst. 92:2000;1764-1772.
53. Nelson H.H., Christiani D.C., Mark E.J., et al. Implications and prognostic value of K-ras mutation for early-stage lung cancer in women. J Natl Cancer Inst. 91:1999;2032-2038.
54. Mollerup S., Ryberg D., Hewer A., et al. Gender differences in CYP1A1 expression among lung cancer patients. Proc Am Assoc Cancer Res. 39:1998;337.
55. Benowitz N.L., Jacob P. Daily intake of nicotine during cigarette smoking. Clin Pharmacol Ther. 35:1984;499-504.
56. Beckett A.H., Gorrod J.W., Jenner P. The effect of smoking on nicotine metabolism in vivo in man. J Pharm Pharmacol. 23:(suppl):1971;62S-67S.
57. Gold D.R., Wang X., Wypij D., et al. Effects of cigarette smoking on lung function in adolescent boys and girls. N Engl J Med. 335:1996;931-937.
58. Siegfried J.M., Krishnamachary N., Gaither Davis A., et al. Evidence for autocrine actions of neuromedin B and gastrin-releasing peptide in non-small cell lung cancer. Pul Pharmacol Ther. 12:1999;291-302.
59. Ishikawa-Brush Y., Powell J.F., Bolton P., et al. Autism and multiple exostoses associated with an X;8 translocation occurring within the GRPR gene and 3' to the SDC2 gene. Hum Mol Genet. 6:1997;1241-1250.
60. Shriver S.P., Bourdeau H.A., Gubish C.T., et al. Sex-specific expression of gastrin-releasing peptide receptor: relationship to smoking history and risk of lung cancer. J Natl Cancer Inst. 92:2000;24-33.
61. Taioli E., Wynder E.L. Endocrine factors and adenocarcinoma of the lung in women. J Natl Cancer Inst. 84:1994;869-870.
62. Sellers T.A., Potter J.D., Folsom A.R. Association of incident lung cancer with family history of female reproductive cancers: the Iowa Women's Health Study. Genet Epidemiol. 8:1991;199-208.
63. Liao M.L., Wang J.H., Wang H.M., et al. A study of the association between squamous cell carcinoma and adenocarcinoma in the lung, and history of menstruation in Shanghai women, China. Lung Cancer. 14:(suppl 1):1996;S215-S221.
64. Adami H.O., Persson I., Hoover R., et al. Risk of cancer in women receiving hormone replacement therapy. Intl J Cancer. 44:1989;833-839.
65. Canver C.C., Memoli V.A., Vanderveer P.L., et al. Sex hormone receptors in non-small cell lung cancer in human beings. J Thorac Cardiovasc Surg. 108:1994;153-157.
66. Kaiser U., Hofmann J., Schilli M., et al. Steroid-hormone receptors in cell lines and tumor biopsies of human lung cancer. Int J Cancer. 67:1996;357-364.
67. Ollayos C.W., Riordan G.P., Rushkin J.M. Estrogen receptor detection in paraffin sections of adenocarcinoma of the colon, pancreas, and lung. Arch Pathol Lab Med. 118:1994;630-632.
68. Cagle P.T., Mody D.R., Schwartz M.R. Estrogen and progesterone receptors in bronchogenic carcinoma. Cancer Res. 50:1990;6632-6635.
69. Enmark E., Pelto-Huikko M., Grandien S.L., et al. Human estrogen receptor beta gene structure, chromosomal localization and expression pattern. J Clin Endocrinol Metab. 82:1997;4258-4265.
70. Mosselman S., Polman J., Dijkema R. ERβ: Identification and characterization of a novel estrogen receptor. FEBS Lett. 392:1996;49-53.
71. Paech K., Webb P., Kiuper G.J.M., et al. Differential ligand activation of estrogen receptors ERα and ERβ at AP1 sites. Science. 277:1997;1508-1510.
72. Kiuper G.G.J.M., Carlsson B., Grandien K., et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β Endocrinology. 138:1997;863-869.
73. Siegfried J.M., Gaither Davis A.L., Gupta C. Role of estrogens in non-small cell lung cancer. Proc Am Assoc Cancer Res. 41:2000;136.
74. Yager J.D., Liehr J.G. Molecular mechanisms of estrogen carcinogenesis. Annu Rev Pharmacol Toxicol. 36:1996;203-232.
75. Fishman J. Biological action of catechol estrogens. J Endocrinol. 85:1981;59-65.
76. Hom Y.K., Young P., Wiesen J.F., et al. Organ growth requires epidermal growth factor receptor signaling from stroma. Endocrinology. 139:1998;913-921.
77. Skilrud D., Offord K., Miller R. Higher risk of lung cancer in chronic obstructive pulmonary disease. Ann Intern Med. 105:1986;503-507.
78. Simpson E.R., Michael M.D., Agarwal V.R., et al. Cytochromes P450 11: expression of the CYP19 (aromatase) gene: as unusual case of alternative promoter usage. FASEB J. 11:1997;29-36.